To date, it has been reported that the level of PHGDH protein is increased in 16% of all cancers 32, 40% of melanoma samples 4, 70% of estrogen receptor (ER)-negative and triple-negative breast cancer samples, and even associated with subtypes of breast cancers33. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.